{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:37:17Z","timestamp":1790786237558,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T00:00:00Z","timestamp":1564099200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T00:00:00Z","timestamp":1564099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["project Metarthros"],"award-info":[{"award-number":["project Metarthros"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC1181 (project INST 90\/925-1)"],"award-info":[{"award-number":["CRC1181 (project INST 90\/925-1)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FOR 2886 (project SCHE 1583\/15-1)"],"award-info":[{"award-number":["FOR 2886 (project SCHE 1583\/15-1)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["project SCHE 1583\/14-1"],"award-info":[{"award-number":["project SCHE 1583\/14-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["RTCure (115142)"],"award-info":[{"award-number":["RTCure (115142)"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014034","name":"Foundation for Research in Rheumatology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014034","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13075-019-1957-0","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T06:03:04Z","timestamp":1564120984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation\u2014data from the prospective IVEPSA study"],"prefix":"10.1186","volume":"21","author":[{"given":"Eleni","family":"Kampylafka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"d\u2019Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Linz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Lerchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Englbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Rech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnd","family":"Kleyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sticherling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Schett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel J.","family":"Hueber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,26]]},"reference":[{"key":"1957_CR1","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376:2095\u20136.","journal-title":"N Engl J Med"},{"key":"1957_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41584-018-0091-8","volume":"14","author":"EM Gravallese","year":"2018","unstructured":"Gravallese EM, Schett G. Effects of the IL-23-IL-17 pathway on bone in spondyloarthritis. Nat Rev Rheumatol. 2018;14:631\u201340.","journal-title":"Nat Rev Rheumatol"},{"key":"1957_CR3","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/art.23104","volume":"57","author":"V Chandran","year":"2007","unstructured":"Chandran V, Schentag CT, Gladman DD. Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum. 2007;57:1560\u20133.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1957_CR4","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3899\/jrheum.080596","volume":"36","author":"SALVATORE D\u2019ANGELO","year":"2009","unstructured":"D\u2019Angelo S, Mennillo GA, Cutro MS, Leccese P, Nigro A, Padula A, Olivieri I Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. J Rheumatol. 2009;36:368\u2013370.","journal-title":"The Journal of Rheumatology"},{"key":"1957_CR5","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1186\/2193-1801-3-759","volume":"3","author":"F Caso","year":"2014","unstructured":"Caso F, Costa L, Atteno M, Del Puente A, Cantarini L, Lubrano E, Scarpa R. Simple clinical indicators for early psoriatic arthritis detection. Springerplus. 2014;3:759.","journal-title":"Springerplus."},{"key":"1957_CR6","first-page":"668","volume":"35","author":"UR Lindqvist","year":"2008","unstructured":"Lindqvist UR, Alenius GM, Husmark T, Theander E, Holmstr\u00f6m G, Larsson PT. Psoriatic Arthritis Group of the Society for Rheumatology. The Swedish early psoriatic arthritis register-- 2-year followup: a comparison with early rheumatoid arthritis. J Rheumatol. 2008;35:668\u201373.","journal-title":"J Rheumatol"},{"key":"1957_CR7","first-page":"11","volume":"33","author":"B Kirkham","year":"2015","unstructured":"Kirkham B, De Vlam K, Li W, Boggs R, Malbris L, Nab HW, Tarallo M. Early treatment of psoriatic arthritis is associated with improved patient-related outcomes: findings from the etanercept PRESTA trial. Clin Exp Rheumatol. 2015;33:11\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"1957_CR8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.rdc.2012.05.005","volume":"38","author":"DD Gladman","year":"2012","unstructured":"Gladman DD. Early psoriatic arthritis. RhemDis Clin North Am. 2012;38:373\u201386.","journal-title":"RhemDis Clin North Am"},{"issue":"3","key":"1957_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41584-019-0175-0","volume":"15","author":"Jose U. Scher","year":"2019","unstructured":"Scher J, Ogdie A, Merola JF, Ritchlin D. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat Rev Rheumatol. 2019;15:153-166.","journal-title":"Nature Reviews Rheumatology"},{"key":"1957_CR10","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1016\/S0140-6736(18)31217-0","volume":"391","author":"P Nash","year":"2018","unstructured":"Nash P. Psoriatic arthritis: novel targets add to therapeutic renaissance. Lancet. 2018;391:2187\u20139.","journal-title":"Lancet"},{"key":"1957_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41584-019-0175-0","volume":"15","author":"JU Scher","year":"2019","unstructured":"Scher JU, Ogdie A, Merola JF, Ritchlin C. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat Rev Rheumatol. 2019;15:153\u201366.","journal-title":"Nat Rev Rheumatol"},{"key":"1957_CR12","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/art.39973","volume":"69","author":"L Eder","year":"2017","unstructured":"Eder L, Polachek A, Rosen CF, Chandran V, Cook R, Gladman DD. The development of psoriatic arthritis in patients with psoriasis is preceded by a period of nonspecific musculoskeletal symptoms: a prospective cohort study. Arthritis Rheumatol. 2017;69:622\u20139.","journal-title":"Arthritis Rheumatol"},{"key":"1957_CR13","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1136\/annrheumdis-2015-208821","volume":"75","author":"F Faustini","year":"2016","unstructured":"Faustini F, et al. Subclinical joint inflammation in patients with psoriasis without concomitant psoriatic arthritis: a cross-sectional and longitudinal analysis. Ann Rheum Dis. 2016;75:2068\u201374.","journal-title":"Ann Rheum Dis"},{"key":"1957_CR14","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/jid.2013.404","volume":"134","author":"AL Croxford","year":"2014","unstructured":"Croxford AL, Karbach S, Kurschus FC, W\u00f6rtge S, Nikolaev A, Yogev N, Klebow S, Sch\u00fcler R, Reissig S, Piotrowski C, Brylla E, Bechmann I, Scheller J, Rose-John S, Thomas Wunderlich F, M\u00fcnzel T, von Stebut E, Waisman A. IL-6 regulates neutrophil microabscess formation in IL-17A-driven psoriasiform lesions. J Invest Dermatol. 2014;134:728\u201335.","journal-title":"J Invest Dermatol"},{"key":"1957_CR15","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.4049\/jimmunol.1700596","volume":"200","author":"A Soare","year":"2018","unstructured":"Soare A, Weber S, Maul L, Rauber S, Gheorghiu AM, Luber M, Houssni I, Kleyer A, von Pickardt G, Gado M, Simon D, Rech J, Schett G, Distler JHW, Ramming A. Cutting edge: homeostasis of innate lymphoid cells is imbalanced in psoriatic arthritis. J Immunol. 2018;200:1249\u201354.","journal-title":"J Immunol"},{"key":"1957_CR16","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1056\/NEJMoa1412679","volume":"373","author":"PJ Mease","year":"2015","unstructured":"Mease PJ, McInnes IB, Kirkham B, Kavanaugh A, Rahman P, van der Heijde D, Landew\u00e9 R, Nash P, Pricop L, Yuan J, Richards HB, Mpofu S, FUTURE 1 study group. Secukinumab inhibition of interleukin-17A in patients with psoriatic arthritis. N Engl J Med. 2015;373:1329\u201339.","journal-title":"N Engl J Med"},{"key":"1957_CR17","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S0140-6736(15)61134-5","volume":"386","author":"IB McInnes","year":"2015","unstructured":"McInnes IB, Mease PJ, Kirkham B, Kavanaugh A, Ritchlin CT, Rahman P, van der Heijde D, Landew\u00e9 R, Conaghan PG, Gottlieb AB, Richards H, Pricop L, Ligozio G, Patekar M, Mpofu S, FUTURE 2 study group. Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2015;386:1137\u201346.","journal-title":"Lancet."},{"issue":"1","key":"1957_CR18","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/ar2936","volume":"12","author":"IE Adamopoulos","year":"2010","unstructured":"Adamopoulos IE, et al. Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors. Arthritis Res Ther. 2010;12(1):R29.","journal-title":"Arthritis Res Ther"},{"key":"1957_CR19","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/nm.2854","volume":"18","author":"RJ Lories","year":"2012","unstructured":"Lories RJ, McInnes IB. Primed for inflammation: enthesis-resident T cells. Nat Med. 2012;18:1018\u20139.","journal-title":"Nat Med"},{"key":"1957_CR20","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1002\/art.39685","volume":"68","author":"D van der Heijde","year":"2016","unstructured":"van der Heijde D, et al. Brief report: secukinumab provides significant and sustained inhibition of joint structural damage in a phase III study of active psoriatic arthritis. Arthritis Rheumatol. 2016;68:1914\u201321.","journal-title":"Arthritis Rheumatol"},{"key":"1957_CR21","first-page":"890","volume":"77","author":"P Mease","year":"2018","unstructured":"Mease P, et al. Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study. Ann Rheum Dis. 2018;77:890\u20137.","journal-title":"Ann Rheum Dis"},{"key":"1957_CR22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13075-018-1653-5","volume":"20","author":"E Kampylafka","year":"2018","unstructured":"Kampylafka E, et al. Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study. Arthritis Res Ther. 2018;20:153.","journal-title":"Arthritis Res Ther"},{"key":"1957_CR23","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1136\/annrheumdis-2014-206347","volume":"75","author":"D Simon","year":"2016","unstructured":"Simon D, et al. Analysis of periarticular bone changes in patients with cutaneous psoriasis without associated psoriatic arthritis. Ann Rheum Dis. 2016;75:660\u20136.","journal-title":"Ann Rheum Dis"},{"key":"1957_CR24","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3899\/jrheum.090352","volume":"36","author":"M Ostergaard","year":"2009","unstructured":"Ostergaard M, et al. The OMERACT psoriatic arthritis magnetic resonance imaging scoring system (PsAMRIS): definitions of key pathologies, suggested MRI sequences, and preliminary scoring system for PsA hands. J Rheumatol. 2009;36:1816\u201324.","journal-title":"J Rheumatol"},{"issue":"12","key":"1957_CR25","doi-asserted-by":"publisher","first-page":"6508","DOI":"10.1210\/jc.2005-1258","volume":"90","author":"S Boutroy","year":"2005","unstructured":"Boutroy S, Bouxsein ML, Munoz F, Delmas PD. In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab. 2005;90(12):6508\u201315.","journal-title":"J Clin Endocrinol Metab"},{"key":"1957_CR26","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1136\/annrheumdis-2017-212404","volume":"77","author":"F Stemmler","year":"2018","unstructured":"Stemmler F, Simon D, Liphardt AM, Englbrecht M, Rech J, Hueber AJ, et al. Biomechanical properties of bone are impaired in patients with ACPA-positive rheumatoid arthritis and associated with the occurrence of fractures. Ann Rheum Dis. 2018;77:973\u201380.","journal-title":"Ann Rheum Dis"},{"key":"1957_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0021-9290(95)80008-5","volume":"28","author":"B Van Rietbergen","year":"1995","unstructured":"Van Rietbergen B, Weinans H, Huiskes R, Odgaard A. A new method to determine trabecular bone elastic properties and loading using micromechanical finite-element models. J Biomech. 1995;28:69\u201381.","journal-title":"J Biomech"},{"key":"1957_CR28","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S8756-3282(02)00736-6","volume":"30","author":"W Pistoia","year":"2002","unstructured":"Pistoia W, van Rietbergen B, Lochmuller EM, Lill CA, Eckstein F, Ruegsegger P. Estimation of distal radius failure load with micro-finite element analysis models based on three-dimensional peripheral quantitative computed tomography images. Bone. 2002;30:842\u20138.","journal-title":"Bone."},{"key":"1957_CR29","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.bone.2008.01.017","volume":"42","author":"JA Macneil","year":"2008","unstructured":"Macneil JA, Boyd SK. Bone strength at the distal radius can be estimated from high-resolution peripheral quantitative computed tomography and the finite element method. Bone. 2008;42:1203\u201313.","journal-title":"Bone."},{"key":"1957_CR30","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/acr.20401","volume":"63","author":"L Eder","year":"2011","unstructured":"Eder L, Chandran V, Shen H, Cook RJ, Shanmugarajah S, Rosen CF, Gladman DD. Incidence of arthritis in a prospective cohort of psoriasis patients. Arthritis Care Res (Hoboken). 2011;63:619\u201322.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1957_CR31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/art.24172","volume":"61","author":"FC Wilson","year":"2009","unstructured":"Wilson FC, et al. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum. 2009;61:233\u20139.","journal-title":"Arthritis Rheum"},{"key":"1957_CR32","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1093\/rheumatology\/ker078","volume":"50","author":"E Naredo","year":"2011","unstructured":"Naredo E, M\u00f6ller I, de Miguel E, Batlle-Gualda E, et al. High prevalence of ultrasonographic synovitis and enthesopathy in patients with psoriasis without psoriatic arthritis: a prospective case-control study. Rheumatology (Oxford). 2011;50:1838\u201348.","journal-title":"Rheumatology (Oxford)"},{"key":"1957_CR33","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.jbspin.2016.10.005","volume":"84","author":"M Acquitter","year":"2017","unstructured":"Acquitter M, Misery L, Saraux A, Bressollette L, Jousse-Joulin S. Detection of subclinical ultrasound enthesopathy and nail disease in patients at risk of psoriatic arthritis. Joint Bone Spine. 2017;84:703\u20137.","journal-title":"Joint Bone Spine"},{"key":"1957_CR34","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1136\/ard.2010.132423","volume":"70","author":"S Finzel","year":"2011","unstructured":"Finzel S, Englbrecht M, Engelke K, Stach C, Schett G. A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritis. Ann Rheum Dis. 2011;70:122\u20137.","journal-title":"Ann Rheum Dis"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1957-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-019-1957-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1957-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T19:11:55Z","timestamp":1595617915000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-019-1957-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,26]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1957"],"URL":"https:\/\/doi.org\/10.1186\/s13075-019-1957-0","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,26]]},"assertion":[{"value":"6 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"IVEPSA was part of the PSARTROS study program (NCT02483234) with two separate studies, one on PsA and one patient at high risk to develop PsA. All patients provided written informed consent, and institutional review board (IRB)\/ethics committee (Ethik-Kommission der Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg) approved the protocol (EC 63_15Az; IRB 2355\/01).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"178"}}